At a glance: key differences
- Mechanism: Semaglutide is a GLP‑1 receptor agonist; tirzepatide targets GLP‑1 and GIP (dual agonist).
- Average weight loss: Semaglutide (Wegovy) trials reported around 15% mean loss; tirzepatide (Mounjaro) SURMOUNT‑1 showed around 21% at the highest dose, alongside lifestyle changes.
- Speed: Tirzepatide often reaches larger reductions by month 6–9; semaglutide shows steady loss through 68 weeks in STEP trials.
- Tolerability: Both commonly cause GI symptoms (nausea, reflux, diarrhoea/constipation). Careful dose escalation reduces risk.
- Cost and access (AU): Private pricing varies and supply fluctuates. PBS subsidies generally apply only for approved indications like type 2 diabetes—not cosmetic weight loss. Check current listings.
Weight loss results compared
Headline findings from large trials and real‑world summaries suggest tirzepatide achieves greater average weight loss than semaglutide at maintenance dose, though both can be effective when combined with nutrition, activity and ongoing support.
- Semaglutide (Wegovy; STEP program): approximately 10–15% average body weight reduction over 68 weeks, with a subset reaching 15%+.
- Tirzepatide (Mounjaro; SURMOUNT‑1): approximately 15–21% average reduction at 10–15 mg over 72 weeks, with a larger share of patients achieving 15–20%+ loss.
Individual response varies. Baseline BMI, dose reached, adherence, side‑effect management and behavioural support all influence outcomes. Many people lose most of their weight in the first 6–9 months, then transition to maintenance.
Semaglutide for Weight Loss · Tirzepatide for Weight Loss · Weight Loss Injections Australia
How they work
- Semaglutide: Mimics GLP‑1 to slow gastric emptying, reduce appetite, and improve glucose control.
- Tirzepatide: Activates GLP‑1 and GIP receptors, which may enhance satiety and metabolic effects beyond GLP‑1 alone.
In practice, both reduce hunger, cravings and portion sizes. Clinical programs typically pair them with nutrition plans, resistance training and sleep/stress strategies to preserve muscle while reducing fat mass.
GLP‑1 Australia Guide · Mounjaro Australia Guide · Wegovy Australia Guide
Who each option may suit
- Semaglutide may suit people who prefer a well‑established GLP‑1 with steady weekly titration and extensive weight‑management data.
- Tirzepatide may suit those seeking larger average reductions or with weight‑related metabolic risks where dual agonism could offer additional benefit.
Suitability depends on your medical history, medications, side‑effect tolerance and access. A prescriber will screen for contraindications and set a titration plan.
Side effects and warnings
Common effects (both):
- Nausea, reflux/heartburn, bloating, diarrhoea or constipation
- Decreased appetite, early satiety, taste changes
- Headache, fatigue, injection site reactions
Less common but serious risks discussed with prescribers include:
- Gallbladder issues (e.g., gallstones), pancreatitis symptoms (severe abdominal pain)
- Kidney concerns with severe dehydration from vomiting/diarrhoea
- Thyroid C‑cell tumour warnings in product information; generally avoided with a personal/family history of medullary thyroid carcinoma (MTC) or MEN2
Not typically used during pregnancy or breastfeeding. Report persistent or severe symptoms promptly. Never combine with unapproved or counterfeit products.
Semaglutide Side Effects · Mounjaro Side Effects · Peptide Side Effects Guide
Cost in Australia
Pricing changes with dose strength, clinic fees and supply. PBS subsidies in Australia generally apply only for approved indications (such as type 2 diabetes) and not for weight loss treatment. Always confirm current availability and PBS status with your prescriber and pharmacist.
- Semaglutide brands: Ozempic (T2D), Wegovy (weight management). Private weight‑management use is usually out‑of‑pocket.
- Tirzepatide brand: Mounjaro (T2D with weight‑loss interest). Weight‑management use is typically private unless PBS criteria for diabetes are met.
- Clinic costs: Expect initial consults, follow‑ups and program support fees in addition to medication.
Semaglutide Cost Australia · Mounjaro Cost Australia · Peptide Clinic Cost Australia
Dosing and timelines
- Weekly injections with gradual up‑titration to improve tolerability.
- Many notice appetite changes in weeks 1–4; larger weight changes accrue across months 2–6 and beyond.
- Titration pauses or dose reductions are common if GI effects occur.
Semaglutide Dosage Guide · Tirzepatide Dosage Guide · Semaglutide Results Timeline · Tirzepatide Results Timeline
Access and eligibility (AU)
- Prescription only. Assessment considers BMI, comorbidities, prior attempts, medication interactions and contraindications.
- Telehealth is common; dispensing occurs via registered Australian pharmacies when stock is available.
- Avoid grey‑market or imported versions outside TGA rules due to counterfeit and safety risks.
Buy Semaglutide Australia: Safer Routes · Buy Tirzepatide Australia: Safer Routes · Are Peptides Legal in Australia?
Which is better for weight loss: semaglutide or tirzepatide?
Trial averages favour tirzepatide for greater mean loss at higher doses, but “better” depends on your goals, side‑effect tolerance, medical history, availability and cost. Some patients respond exceptionally well to semaglutide, others to tirzepatide.
The most reliable path is a supervised program with nutrition, activity, sleep and psychological support, plus dose adjustment when needed.
Frequently asked questions
Is tirzepatide stronger than semaglutide for weight loss?
On average, high‑dose tirzepatide produced greater weight loss than semaglutide in head‑to‑head summaries of major trials. Individual response varies and tolerability matters.
How fast will I lose weight?
Most see gradual weekly changes. Meaningful reductions typically build across 2–6 months, with ongoing loss toward 12–18 months if adherence is maintained.
Can I switch from semaglutide to tirzepatide (or vice versa)?
Yes, under medical guidance. Clinicians usually plan a careful transition, adjust dose and monitor side effects.
Are these medicines on the PBS for weight loss?
No. PBS subsidies generally apply to type 2 diabetes indications, not weight management. Confirm current PBS listings with your prescriber and pharmacist.
What if I get nausea or reflux?
Report it early. Strategies include slower titration, smaller meals, lower fat intake, hydration and temporary dose holds or reductions.
Will I regain weight if I stop?
Many do regain some weight after stopping. Lifestyle habits, strength training and a maintenance plan help reduce rebound.
Is compounding an option in Australia?
Access is tightly regulated and subject to TGA rules. Discuss only with legitimate prescribers and registered Australian pharmacies to avoid unsafe or counterfeit products.
Who should avoid these medicines?
People with a personal/family history of MTC or MEN2, active pancreatitis, or certain GI conditions may be advised against use. Pregnancy and breastfeeding are generally not recommended.
Talk to an Australian provider
Send a confidential request. A member of our network can outline eligibility, current availability and next steps.
Your details are used to respond to your enquiry. Do not include sensitive health information. In emergencies, call 000.
Final takeaways
- Tirzepatide often delivers greater average weight loss; semaglutide remains highly effective and widely used.
- Side‑effect management, dose progression and lifestyle support drive real‑world success for both.
- Choose with a prescriber based on medical history, goals, access and budget.